MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Otsuka Holdings Company ADR (OP:OTSKY)

27.67 -0.16 (-0.56%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,159
Open 27.66
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 27.83
Today's Range 27.61 - 27.69
52wk Range 21.64 - 32.41
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
From TANAKA PRECIOUS METAL GROUP Co., Ltd.
Via JCN Newswire
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
Axsome's AXS-05 met endpoints in Alzheimer's agitation studies, showing long-term safety and tolerability. FDA filing planned for late 2025. 
Via Benzinga

Performance

YTD
+1.8%
+1.8%
1 Month
+0.6%
+0.6%
3 Month
+20.5%
+20.5%
6 Month
+11.3%
+11.3%
1 Year
-4.8%
-4.8%

More News

Read More
TANAKA to Provide Medals Representing the Event Concept with a Design of Gently Curved Circular Expansion for the Tokyo Legacy Half Marathon 2024
From Tanaka Holdings Co., Ltd.
Via JCN Newswire
OTSKY Stock Earnings: Otsuka Holdings Reported Results for Q2 2024
Via InvestorPlace
OTSKY Stock Earnings: Otsuka Holdings Reported Results for Q1 2024
Via InvestorPlace
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
Via Benzinga
Why Are Akebia Therapeutics Shares Falling Today?
Via Benzinga
FDA Rejects Akebia Therapeutics' Vadadustat For CKD-Associated Anemia
Via Benzinga
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
Via Benzinga
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
Via Benzinga
Regulatory Setback For Medtronic's High Blood Pressure Device - FDA Backed Japanese Firms' Similar Device For Uncontrolled Hypertension
Via Benzinga
Individuals With Uncontrolled Hypertension - FDA Adcomm Panel Just Supported Japanese MedTech's Blood Pressure Treatment Device
Via Benzinga
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Via Benzinga
Targeting Autosomal Dominant Polycystic Kidney Disease With Novel Approaches
Via Benzinga
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
Via Benzinga
Has A Sugar Daddy Emerged In The Psychedelic Drug Industry?
Via Talk Markets
4 Pre-Merger SPACs to Buy That Are Poised to Soar
Via InvestorPlace
Topics Electric Vehicles
Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia
Via Benzinga
3 Cheap Pharmaceutical Stocks to Grab Now
Via Talk Markets

Frequently Asked Questions

Is Otsuka Holdings Company ADR publicly traded?
Yes, Otsuka Holdings Company ADR is publicly traded.
What exchange does Otsuka Holdings Company ADR trade on?
Otsuka Holdings Company ADR trades on the OTC Traded
What is the ticker symbol for Otsuka Holdings Company ADR?
The ticker symbol for Otsuka Holdings Company ADR is OTSKY on the OTC Traded
What is the current price of Otsuka Holdings Company ADR?
The current price of Otsuka Holdings Company ADR is 27.67
When was Otsuka Holdings Company ADR last traded?
The last trade of Otsuka Holdings Company ADR was at 10/03/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story